United States · FDA National Drug Code directory
LEVETIRACETAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81033-013_30a4626d-74f4-6385-e063-6394a90a2950
- Product NDC
- 81033-013
- Form
- SOLUTION
- Composition / generic term
- LEVETIRACETAM
- Labeler
- Kesin Pharma Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240718
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 50 CUP, UNIT-DOSE in 1 CARTON (81033-013-50) / 5 mL in 1 CUP, UNIT-DOSE (81033-013-05) · 81033-013-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →